192 related articles for article (PubMed ID: 11326917)
21. [Treatment of pelvic endometriosis with goserelin, an LHRH agonist].
Ventruba P; Crha I; Müller P; Mlyncek M
Ceska Gynekol; 1996 Feb; 61(1):11-6. PubMed ID: 8624587
[TBL] [Abstract][Full Text] [Related]
22. [Value of using gonadotropin-releasing hormone agonist pretreatment in adenomyosis patients before adenomyomectomy].
Tan AL; Luo RY; Gong M
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):909-913. PubMed ID: 28057126
[No Abstract] [Full Text] [Related]
23. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
Song JH; Lu H; Zhang J; Li B
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
[TBL] [Abstract][Full Text] [Related]
24. Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Van Leusden HA
Gynecol Endocrinol; 1994 Sep; 8(3):215-22. PubMed ID: 7847108
[TBL] [Abstract][Full Text] [Related]
25. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.
Orvieto R; Nahum R; Rabinson J; Gemer O; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1398-400. PubMed ID: 18675974
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy rate in endometriosis patients according to the severity of the disease after using a combined approach of laparoscopy, GnRH agonist treatment and in vitro fertilization.
Sõritsa D; Saare M; Laisk-Podar T; Peters M; Sõritsa A; Matt K; Karro H; Salumets A
Gynecol Obstet Invest; 2015; 79(1):34-9. PubMed ID: 25277802
[TBL] [Abstract][Full Text] [Related]
27. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
Lossl K; Loft A; Freiesleben NL; Bangsbøll S; Andersen CY; Pedersen AT; Hartwell D; Andersen AN
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):48-53. PubMed ID: 19261371
[TBL] [Abstract][Full Text] [Related]
28. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
[TBL] [Abstract][Full Text] [Related]
29. [Effect of levonorgestrel-releasing intrauterine system combined with GnRH analogue for treatment of large adenomyosis].
Zheng Z; Wang NN; Wang JH; Gan XQ; Zheng QQ; Ke PQ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):541-3, 546. PubMed ID: 20335132
[TBL] [Abstract][Full Text] [Related]
30. [Cryohormonal treatment of patients with intrauterine endometriosis].
Tumasian KP; Bespoiasnaia VV; Voronovskaia IV
Lik Sprava; 2001; (1):86-7. PubMed ID: 15311703
[TBL] [Abstract][Full Text] [Related]
31. [Gonadotropin-releasing agonist in the therapy of patients with laparoscopically confirmed endometriosis].
Pŭnevska M; Filipov E; Nalbanski A; Nalbanski B
Akush Ginekol (Sofiia); 2004; 43 Suppl 4():58-60. PubMed ID: 15673017
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
33. Results of insemination (AIH) following GnRH treatment of endometriosis.
Keresztúri A; Szöllosi J; Daru J; Koloszár S; Pál A
Arch Androl; 2002; 48(4):243-9. PubMed ID: 12137584
[TBL] [Abstract][Full Text] [Related]
34. Basic and clinical aspects of GnRH-agonists in reproduction.
Schmutzler RK; Diedrich K
Int J Gynaecol Obstet; 1990 Aug; 32(4):311-24. PubMed ID: 1977625
[TBL] [Abstract][Full Text] [Related]
35. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract][Full Text] [Related]
36. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
[TBL] [Abstract][Full Text] [Related]
37. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
38. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial.
Gong L; Zhang S; Han Y; Long Q; Zou S; Cao Y
J Clin Pharmacol; 2015 Aug; 55(8):848-53. PubMed ID: 25694383
[TBL] [Abstract][Full Text] [Related]
39. Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy.
Al-Omari WR; Nassir UN; Izzat B
Int J Gynaecol Obstet; 2001 Jul; 74(1):61-2. PubMed ID: 11430944
[No Abstract] [Full Text] [Related]
40. Adenomyosis: what is the impact on fertility?
Matalliotakis IM; Katsikis IK; Panidis DK
Curr Opin Obstet Gynecol; 2005 Jun; 17(3):261-4. PubMed ID: 15870560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
